Mohammed Nurudeen Ibrahim 个人学术档案

20202021202220236 13 47 45

开放获取的出版物数量

2 篇文章

1 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

Pratikkumar PatelUniversity of Missouri-Kansas City在 mail.umkc.edu 的电子邮件经过验证
John Peter FetseLarkin University在 larkin.edu 的电子邮件经过验证
Bahaa MustafaUniversity of Arkansas for Medical Sciences在 uams.edu 的电子邮件经过验证
Pratik AdhikaryFormulation Scientist在 mail.umkc.edu 的电子邮件经过验证
Chien-Yu LinUniversity of Missouri - Kansas City在 mail.umkc.edu 的电子邮件经过验证
Emmanuel OrmanDepartment of Pharmaceutical Chemistry, University of Health and Allied Sciences在 uhas.edu.gh 的电子邮件经过验证
Sashi KandelUniversity of Missouri-Kansas City在 mail.umkc.edu 的电子邮件经过验证

Mohammed Nurudeen Ibrahim

Phd Student in Pharmaceutical sciences, University of Missouri Kansas City

在 mail.umkc.edu 的电子邮件经过验证 - 首页


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA P Patel, NM Ibrahim, K Cheng Trends in pharmacological sciences 42 (6), 448-460, 2021	52	2021
Synthesis and in vitro antimicrobial and anthelminthic evaluation of naphtholic and phenolic azo dyes JK Adu, CDK Amengor, N Mohammed Ibrahim, C Amaning-Danquah, ... Journal of tropical medicine 2020, 2020	22	2020
Development and validation of UV-visible spectrophotometric method for the determination of 5-hydroxymethyl furfural content in canned malt drinks and fruit juices in Ghana JK Adu, CDK Amengor, E Orman, NM Ibrahim, MO Ifunanya, DF Arthur Journal of Food Quality 2019, 2019	17	2019
Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity P Adhikary, S Kandel, UF Mamani, B Mustafa, S Hao, J Qiu, J Fetse, Y Liu, ... Advanced Therapeutics 4 (7), 2100087, 2021	16	2021
Discovery of cyclic peptide inhibitors targeting PD-L1 for cancer immunotherapy J Fetse, Z Zhao, H Liu, UF Mamani, B Mustafa, P Adhikary, M Ibrahim, ... Journal of Medicinal Chemistry 65 (18), 12002-12013, 2022	7	2022
Abstract LB194: A small molecular-weight anti-lag-3 peptide inhibits colon tumor growth M Alahmari, UF Mamani, Y Guo, CY Lin, MN Ibrahim, Y Li, K Cheng Cancer Research 83 (8_Supplement), LB194-LB194, 2023		2023

系统目前无法执行此操作，请稍后再试。

文章 1–6

每年引用数